目的观察慢性阻塞性肺病(COPD)合并肺动脉高压(PH)和COPD非PH患者血浆脂联素(APN)、血清肿瘤坏死因子α(TNF-α)和C反应蛋白(CRP)的水平,探讨炎症反应在COPD相关PH发病机制中的意义。方法将60例COPD急性加重期患者,根据超声心动图拟诊PH的标准为肺动脉收缩压(PASP)≥40 mmHg,分为COPD合并PH组和COPD非PH组各30例,2组均给予吸氧、抗感染、止咳化痰、平喘等常规对症治疗[平均住院日(13.10±3.20)d,(13.27±4.36)d]。选择同期健康体检者22例。应用酶联免疫吸附法(ELISA)测定血浆APN和血清TNF-α水平,免疫比浊法测定血清CRP,比较3组间血浆APN、血清TNF-α和CRP水平,且观察COPD非PH组和COPD合并PH组治疗前后上述指标的变化,并将血APN、TNF-α和CRP水平与PASP进行相关性分析。结果 COPD非PH组和COPD合并PH组血浆APN、血清TNF-α和CRP水平均较对照组明显升高,差异有统计学意义(P〈0.05);且COPD合并PH组明显高于COPD非PH组(P〈0.05)。与治疗前比较,COPD非PH组与PH组治疗后的PASP、血浆APN、血清TNF-α和CRP水平均明显降低(P〈0.05)。PH组治疗后血浆APN、血清TNF-α和CRP水平明显高于COPD非PH组,差异有统计学意义(P〈0.05)。COPD合并PH组治疗前后血浆APN、血清TNF-α和CRP水平分别与PASP呈正相关(r分别为0.744、0.614、0.482、0.627、0.538、0.493,P〈0.05)。结论血浆APN、血清TNF-α和CRP水平的升高与COPD相关PH患者的PASP的升高相关,说明APN、TNF-α和CRP可能参与COPD相关PH的形成过程。
Objective To investigate the plasma adiponectin( APN),serum tumor necrosis factor α( TNF- α) and C- reactive protein( CRP) in patients with chronic obstructive pulmonary disease( COPD) with and without pulmonary hypertension( PH), and to explore the significance of the inflammatory response in COPD- related PH. Methods60 patients with COPD at acute exacerbation were divided into COPD with PH group and COPD without PH group according to the pulmonary artery systolic pressure( PASP) ≥40 mmHg. And 22 healthy persons were selected as control group. All patients got treatment as oxygen,anti-infection,drugs for relieving cough,sputum and asthma,and other symptomatic and supportive treatment( average length of stay: 13. 10 ± 3. 20 days and 13. 27 ± 4. 36 days). Enzyme linked immunosorbent assay( ELISA) was employed to measure the levels of plasma APN and serum TNF- α. Serum CRP was detected by turbidimetric immunoassay. The plasma APN,serum TNF- α and CRP levels were compared in three groups, the levels of blood APN,TNF- α and CRP were observed before and after treatment,and then the correlation was analyzed in the blood APN,TNF- α and CRP levels and PASP. Results The plasma APN,serum TNF- α and CRP in COPD with PH group and COPD without PH group were significantly higher than those in the control group( P 0. 05); the levels of APN,TNF- α and CRP in the PH group was significantly higher than those in COPD without PH group( P 0. 05). After treatment,compared to that before treatment, the pulmonary artery systolic pressure( PASP),plasma APN,serum TNF- α and CRP levels decreased significantly between COPD with PH group and COPD without PH group( P 0. 05). The levels of plasma APN,serum TNF- α and CRP in the PH group were significantly higher than those in COPD without PH group,the difference was statistically significant( P 0. 05). The plasma APN,serum TNF- α and CRP of COPD with PH group before and after treatment were positively correlated with PASP(